TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IMA

ImageneBio, Inc.

Healthcare · Biotechnology

4.80$ -1.6% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow IMA
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-1,172.5% 348.5% -411.4% -194.5% -474.5% -870.6% -1,314.4% -5,980.5%
42.6% 1.8% 3.3% 1.8% 4.8% 11.1% 14.0% 41.0%
31.7% 8.5% 19.5% 16.7% 48.2% 83.3% 151.3% 1,923.9%
5.9% 461.4% -84.5% -106.6% -96.9% -236.6% -113.7% -2,398.5%
30.8% 2.3% 8.3% 5.7% 9.2% 4.5% 0.0% 0.0%
1,108.0% -2.3% 31.8% -5.7% -635.7% 700.3% -997.2% -726.8%
-0.6% -7.2%
0.0% 214.3% 1,875.0%
118.6% 1,263.7% 425.2% 7.0% 829.5% 197.3% 16,933.5%
-64.5% 464.8% 884.1% 225.0% -1,103.2% 654.7% -2,311.6% 10,301.8%
-1,203.3% 346.2% -419.8% -200.1% -483.7% -875.1% -1,314.4% -5,980.5%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?